Latest Mena Region News

Memphasys Limited secures significant repeat orders from Hamad Medical Corporation, marking a pivotal expansion of its Felix™ system across the MENA region.

Memphasys Limited has completed a $579K shortfall placement, boosting total funds raised to over $1.12 million to support the commercial rollout of its Felix™ System following recent regulatory approvals.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Activeport Group launches the Middle East and North Africa’s inaugural AI-powered Network-to-Network Interconnect Exchange, aiming to tap into the region’s booming A$112 billion telecom market driven by hyperscale AI data centre growth.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Urbanise.com Limited reported a 12.4% revenue increase in Q1 FY2026, driven by its NAB partnership, while investing heavily in its Data and Payments Integration Services (DPIS) with expected cash outflows through FY2026.

Urbanise.com Ltd reported a solid FY2025 with 12.7% growth in Annual Recurring Revenue, underpinned by a strategic partnership with National Australia Bank that includes a 15% equity stake. The company strengthened its cash position and is poised for a new integrated payments solution launch in 2026.

Advanced Health Intelligence Ltd has secured up to AUD 5.5 million from Oakley Capital Partners to support its ASX reinstatement and global growth ambitions, while targeting an additional USD 6 million from strategic investors and unlocking AUD 3 million in R&D grants.

Advanced Health Intelligence Ltd has locked in up to AUD 5.5 million from Oakley Capital Partners, reinforcing its capital base as it pushes toward reinstatement on the ASX and broader growth ambitions.

ReNerve Limited reported a robust 53% increase in annual revenue, driven by strategic partnerships and new regulatory approvals that broaden its global footprint in nerve repair.

Advanced Health Intelligence Ltd (AHI) reports robust commercial progress and strategic funding moves in Q1 2025 despite ongoing ASX trading suspension and recent NASDAQ delisting. Key partnerships and technology validations position the company for a strong global scale-up.